2017 Annual Meeting

American Society for Cytopathology

March 5 2017, 7:30pm to 10:30pm

Description

American Society for Cytopathology

New Frontiers in Cytopathology Practice

Sunday, March 5, 2017
7:30 PM 10:30 PM
CC 301

 

Session Credits: 3 CME and SAMs

 

Moderator: Rana Hoda, MD, FIAC, New York Presbyterian Hospital, New York, NY

Course Description:
The new frontiers in cytopathology will be addressed. (1) Application of cytological techniques in circulating tumor cell specimens: The circulating tumor cell (CTC) field is rapidly advancing with the advent of continuously improving technologies for enriching these rare neoplastic cells from blood. CTCs have the potential to provide useful information for the clinical decision-making process in this era of personalized medicine and targeted therapeutics. CTC samples can be processed in the cytology laboratory with routine methods. (2) Primary HPV testing in cervical cancer screening: In April of 2014, the FDA approved the use of an HPV test (the cobas HPV test) for primary cervical cancer screening for women over the age of 25 years, without the need for a concomitant Pap test. This session will discuss the pros and cons for primary HPV test; (3) Advances in Pancreaticobiliary Cytology: Recent advances in pancreaticobiliary cytology with integrated cytology reporting, use of standardized terminology, new biopsy techniques and molecular testing of pancreatic cyst fluid will be also presented; (4) Ancillary Molecular Testing in Indeterminate Thyroid Nodules: How far have we come? This presentation will provide an overview of types of molecular tests available and the effect of these tests on rate of malignancy and management of indeterminate nodules. (5) Morphology and Molecular Testing in Non-Small Cell Carcinoma of the Lung (NSCLC): This presentation will summarize recent guidelines of the International Association for the Study of Lung Cancer, World Health Organization and Papanicolaou Society of Cytopathology, advances in NSCLC treatment including molecular targeted therapy and immunotherapy and its impact on the practice of cytopathologists.

Upon completion of this educational activity, participants should be better able to:

  • Describe advances and new frontiers in cytopathology practice
  • Understand how to integrate clinical information and ancillary testing of lung, pancreatobiliary and thyroid lesions into cytology report
  • Become familiar with new role of HPV test and circulating tumor cells in cytopathology practice

Agenda

7:30 PM

Welcome and Introduction
Rana Hoda, MD, FIAC, New York Presbyterian Hospital, New York, NY

7:40 PM

Application of Cytological Techniques in Circulating Tumor Cell Specimens
Alarice Lowe, MD, Brigham and Women’s Hospital, Boston, MA

8:05 PM

Primary HPV Testing in Cervical Cancer Screening
Jason Stone, MD, QML Pathology, Brisbane, Australia

8:30 PM

Advances in Pancreaticobiliary Cytology
Martha B. Pitman, MD, Massachusetts General Hospital, Boston, MA

8:55 PM

Ancillary Molecular Testing in Indeterminate” Thyroid Nodules: How Far Have We Come?
William C. Faquin, MD, PhD, Massachusetts General Hospital, Boston, MA

9:25 PM

Morphology and Molecular Testing in Non-Small Cell Carcinoma of Lung
William Travis, MD, Memorial Sloan Kettering Cancer Center, New York, NY

Meetings

home-circle-inset-1
view more